Vor Biopharma Inc. (VOR) NASDAQ

$5.30 -0.03 (-0.56%)

Market Cap: $356.88M

As of 06/07/23 04:00 PM EDT. Market closed.

(VOR)

Vor Biopharma Inc. (VOR)
NASDAQ

$5.30
-0.03 (-0.56%)

Market Cap: $356.88M

As of 06/07/23 04:00 PM EDT. Market closed.

Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to ... read more

Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
135
Address
.
PRICE CHART FOR VOR BIOPHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$5.43
Previous Close
$5.33
Days Range
$5.22 - $5.55
52 week range
$3.48 - $7.57
Volume
94,093
Avg. Volume (30 days)
99,948
Market Cap
$356.88M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
66,956,800
Open
$5.43
Previous Close
$5.33
Days Range
$5.22 - $5.55
52 week range
$3.48 - $7.57
Volume
94,093
Avg. Volume (30 days)
99,948
Market Cap
$356.88M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
66,956,800

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VOR BIOPHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
ANG ROBERTPresident and CEOMay 08, 2023 Option Exercise$4.142,3619,775698,304May 10, 2023, 04:19 PM
Chakraborty TirthaChief Scientific OfficerMay 08, 2023 Option Exercise$4.148753,622141,279May 10, 2023, 04:18 PM
Jorgensen Nathan D.Chief Financial OfficerMay 08, 2023 Option Exercise$4.148343,453153,625May 10, 2023, 04:16 PM
Attar Eyal C.Chief Medical OfficerMay 08, 2023 Option Exercise$4.149694,01253,531May 10, 2023, 04:14 PM
ANG ROBERTPresident and CEOMar 01, 2023 Option Exercise$5.5112,65769,740700,665Mar 02, 2023, 06:39 PM
Chakraborty TirthaChief Scientific OfficerMar 01, 2023 Option Exercise$5.515,57630,724142,154Mar 02, 2023, 06:37 PM
Jorgensen Nathan D.Chief Financial OfficerMar 01, 2023 Option Exercise$5.516,31034,768154,459Mar 02, 2023, 06:35 PM
Jorgensen Nathan D.Chief Financial OfficerMar 01, 2023 Option Exercise$5.516,31034,768154,459Mar 02, 2023, 06:35 PM
RA CAPITAL MANAGEMENT, L.P.DirectorDec 09, 2022 Option Exercise$4.3011,627,90750,000,00220,923,554Dec 09, 2022, 04:32 PM
5AM Ventures VI, L.P.10% OwnerNov 16, 2021 Sale$15.30330,7065,059,8024,595,089Nov 18, 2021, 08:14 PM
PARMAR KUSHDirectorNov 16, 2021 Sale$15.30330,7065,059,8024,595,089Nov 18, 2021, 08:10 PM
Chakraborty TirthaChief Scientific OfficerAug 17, 2021 Option Exercise$1.3617,44623,72720,980Aug 19, 2021, 04:02 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 09, 2021 Buy$18.002,979,56653,632,1888,297,265Feb 09, 2021, 06:25 PM
5AM Ventures VI, L.P.10% OwnerFeb 09, 2021 Buy$18.00555,5559,999,9904,833,959Feb 09, 2021, 06:03 PM
PARMAR KUSHDirectorFeb 09, 2021 Buy$18.00555,5559,999,9904,833,959Feb 09, 2021, 05:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
ANG ROBERTPresident and CEO05/08/20239,775
Chakraborty TirthaChief Scientific Officer05/08/20233,622
Jorgensen Nathan D.Chief Financial Officer05/08/20233,453
Attar Eyal C.Chief Medical Officer05/08/20234,012
ANG ROBERTPresident and CEO03/01/202369,740
Chakraborty TirthaChief Scientific Officer03/01/202330,724
Jorgensen Nathan D.Chief Financial Officer03/01/202334,768
Jorgensen Nathan D.Chief Financial Officer03/01/202334,768
RA CAPITAL MANAGEMENT, L.P.Director12/09/202250,000,002
5AM Ventures VI, L.P.10% Owner11/16/20215,059,802
PARMAR KUSHDirector11/16/20215,059,802
Chakraborty TirthaChief Scientific Officer08/17/202123,727
RA CAPITAL MANAGEMENT, L.P.Director02/09/202153,632,188
5AM Ventures VI, L.P.10% Owner02/09/20219,999,990
PARMAR KUSHDirector02/09/20219,999,990
Load More Insider Transactions
FUNDS WITH A POSITION IN VOR BIOPHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.22,748,8802.77%No changeOther
BAKER BROS. ADVISORS LP633,8480.02%-56.76%Other
BLACKROCK INC.467,5980.00007%97.07%Other
GEODE CAPITAL MANAGEMENT, LLC315,9470.00022%89.46%Other
D. E. SHAW & CO., INC.11,4780.00007%-77.45%Other
RENAISSANCE TECHNOLOGIES LLC28,4000.0002%-38.22%Other
BALYASNY ASSET MANAGEMENT L.P.12,6270.00017%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR VOR BIOPHARMA INC
STOCK BUYBACKS FOR VOR BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2022
12/31/2021
18.30%
4Q

Period of Report: 12/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
18.30%
4Q